Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

NetSol Technologies

• The Trade: NetSol Technologies, Inc. NTWK CEO Najeeb Ghauri acquired a total of 8,500 shares an average price of $1.96. To acquire these shares, it cost around $16,620.
• What’s Happening: NETSOL Technologies reported a year-over-year decrease in fourth-quarter EPS results and issued FY24 revenue guidance.
• What NetSol Technologies Does: NETSOL Technologies is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others.

Vivani Medical

• The Trade: Vivani Medical, Inc. VANI Director Gregg Williams acquired a total of 12,419 shares at an average price of $1.01. To acquire these shares, it cost around $12,513.
• What’s Happening: Vivani Medical recently posted a wider-than-expected second-quarter loss.
• What Vivani Medical Does: Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.

Check This Out: Investor Fear Eases Ahead Of Big Earnings

MiNK Therapeutics

• The Trade: MiNK Therapeutics, Inc. INKT 10% owner Agenus Inc acquired a total of 22,975 shares at an average price of $1.10. The insider spent $25,270 to buy those shares.
• What’s Happening: MiNK Therapeutics recently posted a narrower-than-expected second-quarter loss.
• What MiNK Therapeutics Does: MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.

Sacks Parente Golf

• The Trade: Sacks Parente Golf, Inc. SPGC Director Brett Hoge acquired a total of 30,000 shares at an average price of $1.09. The insider spent around $32,700.
• What’s Happening: The company posted a narrower loss for the second quarter.
• What Sacks Parente Golf Does: Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products.

Don’t forget to check out our premarket coverage here